Akero Therapeutics Inc buy Citigroup Inc.
Start price
13.05.25
/
50%
€35.77
Target price
13.05.26
€70.22
Performance (%)
31.31%
Price
08.12.25
€46.97
Summary
This prediction is currently active. With a performance of 31.31% the BUY prediction by Citigroup_Inc_ is a big success. This prediction currently runs until 13.05.26. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akero Therapeutics Inc | - | - |
| iShares Core DAX® | 3.002% | 3.742% |
| iShares Nasdaq 100 | 2.966% | 1.308% |
| iShares Nikkei 225® | 5.606% | 4.472% |
| iShares S&P 500 | 2.312% | 1.880% |
Comments by Citigroup_Inc_ for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target lowered by analysts at Citigroup Inc. from $80.00 to $78.00. They now have a "buy" rating on the stock.
Ratings data for AKRO provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€53.14
28.01.25
28.01.25
€76.71
28.01.26
28.01.26
-11.61%
08.12.25
08.12.25
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€27.54
18.11.24
18.11.24
€61.49
18.11.25
18.11.25
69.39%
19.11.25
19.11.25